Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CuriosityStream | CURI | Oct 30, 2024 | 2.43 | +0.83 |
Curis | CRIS | Oct 30, 2024 | 4.48 | -3.24 |
CURRENC Group | CURR | Oct 30, 2024 | 2.70 | 0.00 |
Curtiss-Wright | CW | Oct 30, 2024 | 353.74 | -0.07 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Oct 30, 2024 | 40.56 | -1.26 |
Cushman & Wakefield | CWK | Oct 30, 2024 | 13.58 | +0.82 |
Custom Truck One Source | CTOS | Oct 30, 2024 | 3.97 | +9.37 |
Customers Bancorp | CUBI | Oct 30, 2024 | 45.66 | +0.53 |
Customers Bancorp E Pref | CUBI-E | Oct 30, 2024 | 25.55 | +0.39 |
Customers Bancorp F Pref | CUBI-F | Oct 30, 2024 | 25.32 | +0.48 |
Cutera | CUTR | Oct 30, 2024 | 0.64 | -4.11 |
CVB Financial | CVBF | Oct 30, 2024 | 19.74 | +0.51 |
CVD Equipment | CVV | Oct 30, 2024 | 2.96 | -3.58 |
CVR Energy | CVI | Oct 30, 2024 | 17.11 | -5.26 |
Cvr Partners LP Unit | UAN | Oct 30, 2024 | 65.06 | -7.27 |
CVRx | CVRX | Oct 30, 2024 | 14.07 | +31.01 |
CVS Health | CVS | Oct 30, 2024 | 56.39 | +0.25 |
CXApp A | CXAI | Oct 30, 2024 | 1.45 | -3.33 |
CyberArk Software | CYBR | Oct 30, 2024 | 282.94 | -0.98 |
Cybin | CYBN | Oct 30, 2024 | 9.91 | -5.62 |
Cyclacel Pharmaceuticals | CYCC | Oct 30, 2024 | 0.66 | -3.40 |
Cyclacel Pharmaceuticals Pref | CYCCP | Oct 30, 2024 | 7.17 | 0.00 |
Cyclerion Therapeutics | CYCN | Oct 30, 2024 | 3.00 | -1.32 |
Cyclo Therapeutics | CYTH | Oct 30, 2024 | 0.72 | -3.87 |
Cyngn | CYN | Oct 30, 2024 | 3.92 | +8.89 |
Cytek Biosciences | CTKB | Oct 30, 2024 | 4.90 | +1.87 |
Cytokinetics | CYTK | Oct 30, 2024 | 51.31 | -0.39 |
Cytomed Therapeutics | GDTC | Oct 30, 2024 | 2.23 | -4.89 |
CytomX Therapeutics | CTMX | Oct 30, 2024 | 0.99 | -0.70 |
Cytosorbents | CTSO | Oct 30, 2024 | 1.01 | -0.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.